Sanofi’s Nasacort First-In-Class Switch Receives FDA Approval

The firm’s Chattem division will bring the 24-hour nasal allergy spray to market in the spring of 2014.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America